CURRENT EYE RESEARCH, cilt.35, sa.9, ss.771-777, 2010 (SCI-Expanded)
Objectives: To evaluate the effects of topical cyclosporine A (CsA) 0.05% (Restasis) on the signs and symptoms of dry eye, on apoptosis, and on MMP-9 expression in conjunctiva epithelial cells in thyroid orbitopathy (TO)-related dry eye patients.